ZA200706919B - Pharmacogenomic markers for prognosis of solid tumors - Google Patents

Pharmacogenomic markers for prognosis of solid tumors

Info

Publication number
ZA200706919B
ZA200706919B ZA200706919A ZA200706919A ZA200706919B ZA 200706919 B ZA200706919 B ZA 200706919B ZA 200706919 A ZA200706919 A ZA 200706919A ZA 200706919 A ZA200706919 A ZA 200706919A ZA 200706919 B ZA200706919 B ZA 200706919B
Authority
ZA
South Africa
Prior art keywords
prognosis
solid tumors
pharmacogenomic markers
pharmacogenomic
markers
Prior art date
Application number
ZA200706919A
Other languages
English (en)
Inventor
Michael E Burczynski
Strahs Andrew
Slonim Donna
Andrew J Dorner
Immermann Frederick
Natalie C Twine
William L Trepicchio
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ZA200706919B publication Critical patent/ZA200706919B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA200706919A 2005-02-18 2007-08-17 Pharmacogenomic markers for prognosis of solid tumors ZA200706919B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65408205P 2005-02-18 2005-02-18

Publications (1)

Publication Number Publication Date
ZA200706919B true ZA200706919B (en) 2008-06-25

Family

ID=36649050

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200706919A ZA200706919B (en) 2005-02-18 2007-08-17 Pharmacogenomic markers for prognosis of solid tumors

Country Status (15)

Country Link
US (1) US20090061423A1 (fr)
EP (1) EP1849007A2 (fr)
JP (1) JP2008529554A (fr)
KR (1) KR20070115891A (fr)
CN (1) CN101120255A (fr)
AU (1) AU2006214078A1 (fr)
BR (1) BRPI0608429A2 (fr)
CA (1) CA2598393A1 (fr)
CR (1) CR9298A (fr)
IL (1) IL185206A0 (fr)
MX (1) MX2007010001A (fr)
NO (1) NO20074065L (fr)
RU (1) RU2007129864A (fr)
WO (1) WO2006089185A2 (fr)
ZA (1) ZA200706919B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007026896A1 (fr) * 2005-09-02 2007-03-08 Toray Industries, Inc. Composition et procédé de diagnostic d’un cancer du rein et d’évaluation du pronostic vital d’un patient atteint de cancer du rein
US20100222230A1 (en) * 2007-04-11 2010-09-02 The General Hospital Corporation Diagnostic and prognostic methods for renal cell carcinoma
EP3831964A3 (fr) 2010-01-11 2021-10-20 Genomic Health, Inc. Méthode d'utilisation d'une expression génique pour déterminer la probabilité du résultat clinique d'un cancer des reins
AU2015202116B2 (en) * 2010-01-11 2017-06-08 Genomic Health, Inc. Method to use gene expression to determine likelihood of clinical outcome of renal cancer
CA2903878C (fr) 2013-05-30 2020-10-27 Genomic Health, Inc. Algorithme de profil d'expression genique pour le calcul d'un score de recurrence pour un patient atteint d'un cancer renal
JP6427750B2 (ja) * 2013-10-02 2018-11-28 コニカミノルタ株式会社 Ｃｘｃｌ１、ならびにｓｍｏｘおよび／またはｉｄ１の発現量に基づく肺癌患者の予後を判定するためのデータ収集方法およびキット
US20180044736A1 (en) * 2015-02-03 2018-02-15 Cedars-Sinai Medical Center Biomarker based prognostic model for predicting overall survival in patients with metastatic clear cell kidney cancer
US20180100859A1 (en) * 2015-03-24 2018-04-12 Eutropics Pharmaceuticals, Inc. Surrogate functional biomarker for solid tumor cancer
CN111537424B (zh) * 2020-04-26 2022-10-28 北京市神经外科研究所 基于外周血细胞评估脊髓胶质瘤患者预后性的系统
CN111640518A (zh) * 2020-06-02 2020-09-08 山东大学齐鲁医院 一种宫颈癌术后生存预测方法、系统、设备及介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020076735A1 (en) * 1998-09-25 2002-06-20 Williams Lewis T. Diagnostic and therapeutic methods using molecules differentially expressed in cancer cells
JP3944996B2 (ja) * 1998-03-05 2007-07-18 株式会社日立製作所 Ｄｎａプローブアレー
WO2002061144A2 (fr) * 2001-01-31 2002-08-08 Whitehead Institute For Biomedical Research Diagnostic de tumeur cerebrale et prediction de resultat de traitement
US7622260B2 (en) * 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
BR0316111A (pt) * 2002-11-21 2005-09-13 Wyeth Corp Métodos para diagnosticar rcc e outros tumores sólidos

Also Published As

Publication number Publication date
US20090061423A1 (en) 2009-03-05
RU2007129864A (ru) 2009-03-27
CA2598393A1 (fr) 2006-08-24
NO20074065L (no) 2007-11-14
AU2006214078A1 (en) 2006-08-24
BRPI0608429A2 (pt) 2009-12-29
JP2008529554A (ja) 2008-08-07
KR20070115891A (ko) 2007-12-06
IL185206A0 (en) 2008-01-06
CN101120255A (zh) 2008-02-06
EP1849007A2 (fr) 2007-10-31
WO2006089185A3 (fr) 2006-09-28
WO2006089185A2 (fr) 2006-08-24
CR9298A (es) 2007-11-23
WO2006089185A8 (fr) 2007-09-27
MX2007010001A (es) 2007-09-27

Similar Documents

Publication Publication Date Title
ZA200706919B (en) Pharmacogenomic markers for prognosis of solid tumors
HK1220208A1 (zh) 用於酶抑制的化合物
IL189933A0 (en) Rna antagonist compounds for the inhibition of apo-b100 expression
ZA200705783B (en) Amino-imidazolones for the inhibition of ß-secretase
IL179020A0 (en) Compounds for enzyme inhibition
IL197668A0 (en) Rna antagonist compounds for the modulation of pcsk9
IL179812A0 (en) THE IMPORTANCE OF THE GENE HoxB13 FOR CANCER
GB0512805D0 (en) Antenna system for sharing of operation
EP1934603A4 (fr) Biomarqueur servant à détecter un cancer de la prostate
IL227562A (en) Symptoms of breast cancer
IL176942A0 (en) Imidazolo-5-yl-2-anilinopyrimidines as agents for the inhibition of cell proliferation
GB0504302D0 (en) Markers for melanoma
EP1908459A4 (fr) Composition prévenant le cancer
GB0421838D0 (en) Cancer markers
IL208214A0 (en) Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
GB0525900D0 (en) Markers
GB0505861D0 (en) Methods for the synthesis of heteroaromatic compounds
GB0604370D0 (en) Markers for melanoma progression
AU158365S (en) Set of fins for surfcraft
PL114723U1 (en) Roof-timber for rectangular lining
GB0427691D0 (en) Markers for inf- response
AU2005901133A0 (en) Improved anchor for refractory linings
SI1948678T1 (sl) Spojine za inhibiranje encimov
GB0417903D0 (en) Hard setting compound
EP2233586A4 (fr) Marqueurs génétiques pour le pronostic de la sclérose en plaques